Posts Tagged: "Congress"

Blatant Mischaracterizations of PERA Hurt Those the Bill Could Help Most

It is time to set the record straight. For reasons I don’t understand, many inventors are just not being truthful about the provisions of patent reform bills now pending in Congress. In fact, some in the independent inventor community are attempting to rally support to kill the overwhelmingly pro-patent, pro-innovation, patent eligibility bill now pending. This is an enormous mistake that will have tragic consequences unless those who have the most to lose become willing to accept a win, even if that win does not provide them with 100% of what they want.

Indie Filmmakers Urge Senate IP Subcommittee to Take Caution in Considering Federal Right of Publicity

The Film Independent and the International Documentary Association (IDA) sent a letter to the  Senate Subcommittee on Intellectual Property Tuesday, asking the Subcommittee to ensure that any federal right of publicity it may be considering as an answer to problems raised by generative AI artificial intelligence (AI) include an express exemption for creative works. The letter, penned by the law firm Donaldson Callif Perez, came in response to the Subcommittee hearing held on July 12, 2023, during which witnesses floated the idea of creating a federal right of publicity or an anti-impersonation right as a solution to concerns that generative AI could mimic artistic styles.

This Week in Washington IP: Improving Invention Education, Intellectual Property Rights During Public Health Emergencies, and the State of the Chinese Economy

This week in Washington IP news, as a new school year begins, the United States Patent and Trademark Office (USPTO) looks at the latest research on invention education. Congress is still on vacation, yet hot topic issues are still being discussed elsewhere, including the Center for Strategic and International Studies (CSIS) looking at the state of the Chinese economy, and the American Enterprise Institute discussing what the U.S. federal government can do to patent rights during a public health emergency.

This Week in Washington IP: How European Tech Regulations Impact U.S. Businesses, The 5G Patent Race, and IP in Latin America

This week in Washington IP news, with Congress still on summer recess we look abroad to Brazil, which will be hosting the largest international intellectual property event in Latin America. Elsewhere, the Cato Institute discusses how EU regulations on tech companies are impacting U.S. businesses, and IPWatchdog hosts a panel on the 5G patent race.

Accelerated Innovation: In Less Than a Year, We’ve Seen a Decade’s Worth of AI and IP Developments

The past year has provided decades’ worth of developments across law and policy in the areas of artificial intelligence (AI) and machine learning (ML) technologies. If 2022 was the breakthrough year for accessible AI, then 2023 can so far be deemed as the first year of likely many more to come in the era of an AI inquisition. “After years of somewhat academic discourse,” reflects Dr. Ryan Abbott, “AI and copyright law have finally burst into the public consciousness—from contributing to the writer’s strike to a wave of high-profile cases alleging copyright infringement from machine learning to global public hearings on the protectability of AI-generated works.” Both the U.S. Copyright Office (USCO) and the U.S. Patent and Trademark Office (USPTO) are in active litigation over the eligibility of generative AI outputs for statutory protection. Additionally, both offices have held numerous webinars and listening sessions and conducted other methods of collecting feedback from the public as they work through policy considerations surrounding AI.

PTAB Developments in 2023: A Mid-Year Recap and What’s to Come

A little over halfway through 2023, and nearing the end of the Patent Trial and Appeal Board’s (PTAB’s) fiscal year, we can take stock of an administrative body that is settling into a decade of precedent while big changes still loom. Unlike prior years, where policy changes resulted in statistical swings for institution rates, outcomes, amendment practice, and the like, this year has been more of an extension of previous trends (though institution rates are still creeping higher).

International Perspectives: R&D and AI Policies in the Global Landscape

Everyone’s talking about artificial intelligence (AI), but not everyone’s talking about it the same way. The tenor of the global conversation on AI ranges from dystopian fearmongering to evangelistic optimism. It’s vital to know the prevailing mood in the territory where you plan to launch your AI-powered service, app, or consultancy. In this article, we’ll briefly tour recent legislation, ethical conversations, and economic strategies to demonstrate how varied current thinking is on this revolutionary new technology. We’ll look at the current situation in the United States, Canada, Europe, China, Japan and beyond, as countries develop the policies, guidelines and laws necessary to regulate AI innovation without stifling creativity.

AI Voice Cloning – and Its Misuse – Has Opened a Pandora’s Box of Legal Issues: Here’s What to Know

Voice cloning, a technology that enables the replication of human voices from large language models using artificial intelligence (AI), presents both exciting possibilities and legal challenges. Recent machine-learning advances have made it possible for people’s voices to be imitated with only a few short seconds of a voice sample as training data. It’s a development that brings exciting possibilities for personalized and immersive experiences, such as creating realistic voiceovers for content, lifelike personal assistants and even preserving the voices of loved ones for future generations. But it’s also ripe with potential for abuse, as it could easily be used to commit fraud, spread misinformation and generate fake audio evidence.

This Week in Washington IP: How to Protect IP in Southeast Asia, Promoting Women in STEM, and Preventing Bank Failures

This week in Washington IP news, while Congress continues its summer recess, the U.S. Patent and Trademark Office (USPTO) hosts several events, including on how to protect your IP in Southeast Asia. The Office also continues its #WEWednesday series, this week with an installment on how to increase the number of women in the STEM field. Elsewhere, the Peterson Institute for International Economics will look at what preventative policy measures are needed to prevent repeat bank failures in the United States.

Gilead Wins Injunction in Counterfeit HIV Meds Case as Coons Recognizes August as National Anticounterfeiting Month

The U.S. District Court for the Eastern District of New York, in a decision published Monday, denied the defendants’ motions to vacate asset freezes in a case brought by Gilead alleging a massive HIV drug counterfeiting ring that involves “hundreds of millions of dollars’ worth” of fake medications. In January 2022, the court unsealed documents in the suit against a slew of defendants who Gilead said sold, marketed, and distributed counterfeits of its HIV medications. Gilead’s complaint sought immediate monetary and injunctive relief, including seizure at certain of the defendants’ premises, as well as relief for trademark and trade dress infringement and trademark dilution, among other alleged violations.

Vidal Tells Senate IP Subcommittee There Will Be Movement on ANPRM Proposals Soon

The Senate Subcommittee on Intellectual Property today held a hearing on Oversight of the United States Patent and Trademark Office (USPTO), with USPTO Director Kathi Vidal as the sole witness. Only a handful of senators questioned Vidal, and only one significantly challenged her in questioning. The hearing differed considerably from the House IP Subcommittee’s Oversight Hearing in April, where Vidal was repeatedly taken to task on the Office’s then-recently issued Advance Notice of Proposed Rulemaking (ANPRM).

ITIF White Paper Advocates for Greater Federal Tax Credits to Keep U.S. Ahead of China in R&D

Today, the Information Technology & Innovation Foundation (ITIF) published a white paper titled Innovation Wars: How China Is Gaining on the United States in Corporate R&D showing that, while the United States continues to enjoy a lead in several key sectors when surveying the world’s largest corporate investors in research and development (R&D), its largest economic rival is gaining and could achieve parity with the U.S. in about a decade.

This Week in Washington IP: Increasing Women’s Entrepreneurship, Expanding STEM Education, and Competing Autonomous Vehicle Competition with China

This week in Washington IP news, a House subcommittee is turning its attention to self-driving cars and how U.S. companies can compete with their Chinese counterparts. The Senate Small Business Committee will host several women entrepreneurs to testify on how women’s participation in business can be increased. Elsewhere, the U.S. Copyright Office (USCO) is meeting to discuss generative AI’s impact on copyright law and policy.

Pandemic Response Reauthorization Bill Advances Out of Senate HELP Committee with Anti-Patent Provisions Intact

On Thursday morning, the U.S. Senate Committee on Health, Education, Labor & Pensions (HELP) held a legislative markup hearing to debate amendments to S. 2333, the Pandemic and All-Hazards Preparedness and Response Act (PAHPARA), the reauthorization bill to extend the Pandemic and All-Hazards Preparedness Act (PAHPA). If enacted as currently drafted, PAHPARA would direct federal agencies to study alternative models for funding biomedical research, including prize systems that have been routinely rejected as a viable model by pro-innovation advocates.

Finding the Trolls: My Mission to Understand Why We Need the PTAB

I was told that elected officials count on—in fact, they need—constituent input to be effective legislators. After my patents were unjustly cancelled at the Patent Trial and Appeal Board (PTAB), I started the journey to do this very thing. Since January of 2022, I have visited Congress and the Senate two dozen times. I have visited over 200 offices telling my story and advocating for the “little” inventors, like me.

Varsity Sponsors

IPWatchdog Events

Patent Portfolio Management Masters™ 2024
June 24 @ 1:00 pm - June 26 @ 2:00 pm EDT
Webinar – Sponsored by LexisNexis
August 22 @ 12:00 pm - 1:00 pm EDT
Women’s IP Forum
August 26 @ 11:00 am - August 27 @ 5:00 pm EDT
IP Solutions, Services & Platforms Expo
September 9 @ 1:00 pm - September 10 @ 2:00 pm EDT
Webinar – Sponsored by Anaqua
September 19 @ 12:00 pm - 1:00 pm EDT

From IPWatchdog